Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma

Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion.

Index Ventures led the round alongside Kleiner Perkins, Sequoia Capital and Dimension.

New investors joining the investment included Bain Capital Ventures, […]

The post https://siliconangle.com/2026/07/14/chai-discovery-nabs-400m-series-c-ai-designed-antibodies-reach-big-pharma/" rel="nofollow">Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma appeared first on https://siliconangle.com" rel="nofollow">SiliconANGLE.